Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
NeuroBo Pharmaceuticals ( (NRBO) ) just unveiled an update.
NeuroBo Pharmaceuticals is set to rebrand as MetaVia Inc. on November 29, 2024, with a new Nasdaq ticker symbol, MTVA, reflecting its focus on cardiometabolic diseases. This strategic realignment accompanies significant clinical milestones, including trials for DA-1241 and DA-1726, targeting conditions like obesity and MASH. Despite the name change, shareholders’ rights remain unaffected, and operations continue as usual, supported by a strong financing background.
Learn more about NRBO stock on TipRanks’ Stock Analysis page.
